Janus Henderson Horizon Biotechnology Fund H2 - WKN A2N85W, ISIN LU1897414485

Ex-Date	Pay Date	Amount	Change
No dividends history available for Janus Henderson Horizon Biotechnology Fund H2.

Date	Ratio
No splits history available for Janus Henderson Horizon Biotechnology Fund H2.

Janus Henderson Horizon Biotechnology Fund H2 currently pays no dividends.

6 Countries: United States
86.83%
United Kingdom
5.64%
Denmark
3.11%
France
1.95%
Canada
1.34%
Netherlands
1.13%
1 Sector: Health Care
100.00%
57 Holdings: Sarepta Therapeutics Inc5.69%
Vertex Pharmaceuticals Inc5.13%
argenx SE ADR4.54%
Horizon Therapeutics PLC3.71%
BioMarin Pharmaceutical Inc3.64%
Illumina Inc3.29%
United Therapeutics Corp3.15%
AstraZeneca PLC ADR2.88%
AbbVie Inc2.84%
Ascendis Pharma AS ADR2.75%
Aristocrats see all 57 holdings

Resources

Similar securities

Security	Div.%	Div.CAGR 5Y	Div.Freq.	Sector	Type
Global X EURO STOXX 50 Covered Call UCITS ETF DisAd	8.26%	-	monthly	mixed	ETF
SPDR S&P US Dividend Aristocrats UCITS ETF Dis	2.07%	#.##%	quarterly	mixed	ETF
DNB Fund - Technology Retail A (EUR) SEK	-	#.##%	none	mixed	Fund
Vanguard Emerging Markets Stock Index Fund EUR Acc	-	#.##%	none	mixed	Fund
Janus Henderson Horizon Global Smaller Companies Fund H2	-	#.##%	none	mixed	Fund